Stanford CARE Lung Cancer Initiative
Stanford CARE Lung Cancer Summit: Understanding Lung Cancer in People who have Never Smoked
The Stanford Center for Asian Health Research and Education (CARE) will be hosting the 2025 Stanford CARE Lung Cancer Summit: Understanding Lung Cancer in People who have Never Smoked at Stanford University March 11-12, 2025.
Lung cancer in people who have never smoked disproportionately affects Asian populations, with studies indicating higher incidence rates among non-smoking Asian women compared to other ethnic groups. This alarming trend suggests a genetic predisposition and highlights the urgent need for targeted innovative research, clinical guidance, public health policy, and awareness campaigns to address this specific health disparity. This multidisciplinary summit will bring together experts in basic and translational research, physicians, and advocacy groups from around the world to share cutting-edge research and discoveries, all with the common goal of creating a coordinated roadmap to address the healthcare disparities that exist in non-smoker lung cancer.
Stanford CARE Monthly Community Health Talk on "Addressing Lung Cancer in Asian Americans: Screening, Treatment, and Advancements."
Stanford CARE Monthly Community Health Talk on "Lung cancer Screening, Incidence, and Outcomes in Asian Americans."
CARE Media Coverage on Non-Smoker Lung Cancer
Dr. Heather Wakelee, MD, FACS, Stanford CARE's Never Smoker Lung Cancer Initiative Lead Faculty and Deputy Director of the Stanford Cancer Institute, was featured in a KPIX media interview discussing never-smoker lung cancer in Asian Americans.
Dr. Jeffrey Velotta, MD, a CARE Global Faculty member, led a thoughtful discussion about lung cancer in the AAPI community, which was highlighted on Fox News.
A New Stanford Course on Non-Smoker Lung Cancer, MED 275: From Diagnosis to Dialogue: A Doctor's Real-Time Battle with Cancer, Will Be Offered This Fall
Dr. Bryant Lin, MD, CARE Co-Founder and Co-Director, and Clinical Professor at Stanford University School of Medicine, provides a first-person perspective on receiving a diagnosis of Stage 4 “Non-Smoker” lung cancer in May 2024, which has metastasized (spread) to his brain, liver, and bones. The course will consist of Dr. Lin sharing his personal experiences accompanied by weekly talks from leading Stanford cancer clinicians and researchers discussing all aspects of Dr. Lin’s case across cancer screening, diagnostics, caregiving, policy, therapy, and spiritual care. This unique course will appeal to students interested in learning about advanced stage cancer from both the patient and physician perspectives almost in real-time.
The course will be offered in Autumn Quarter 2024.